Updated long-term follow-up results of a phase 1b/2 study (FUMANBA-1) in patients with relapsed/refractory multiple myeloma (RRMM) treated with equecabtagene autoleucel

被引：0

作者：

Li, Chunrui ^{[1
]}

Wang, Di ^{[1
]}

Fang, Baijun ^{[2
,3
]}

Huang, He ^{[4
]}

Li, Jianyong ^{[5
]}

Chen, Bing ^{[6
]}

Liu, Jing ^{[7
]}

Ren, Hanyun ^{[8
]}

Dong, Yujun ^{[8
]}

Hu, Kai ^{[9
]}

Liu, Peng ^{[10
]}

Zhang, Xi ^{[11
]}

Mi, Jian-Qing ^{[12
]}

Li, Zhenyu ^{[13
]}

Ding, Kaiyang ^{[14
]}

Cai, Song-Bai ^{[15
]}

Gui, Hong-Yu ^{[15
]}

Wang, Wen ^{[15
]}

Qiu, Lugui ^{[12
]}

机构：

[1] Huazhong Univ Sci & Technol, Dept Hematol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China

[2] Zhengzhou Univ, Dept Hematol, Affiliated Canc Hosp, Zhengzhou, Peoples R China

[3] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China

[4] Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Hangzhou, Peoples R China

[5] Jiangsu Prov Hosp, Nanjing, Peoples R China

[6] Nanjing Med Univ, Dept Hematol, Nanjing Drum Tower Hosp, Clin Coll, Nanjing, Peoples R China

[7] Cent South Univ, Dept Hematol, Xiangya Hosp 3, Changsha, Peoples R China

[8] Peking Univ First Hosp, Dept Hematol, Beijing, Peoples R China

[9] Beijing GoBroad Boren Hosp, Dept Adult Lymphoma, Beijing, Peoples R China

[10] Fudan Univ, Dept Hematol, Zhongshan Hosp, Shanghai, Peoples R China

[11] Army Med Univ, Med Ctr Hematol, Xinqiao Hosp, State Key Lab Trauma Burn & Combined Injury Army, Chongqing, Peoples R China

[12] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Natl Res Ctr Translat Med, Shanghai Inst Hematol,Ruijin Hosp,Sch Med, Shanghai, Peoples R China

[13] Xuzhou Med Univ, Blood Dis Inst, Xuzhou, Jiangsu, Peoples R China

[14] Univ Sci & Technol China, Dept Hematol, Ailiated Hosp 1, Div Life Sci & Med, Hefei, Peoples R China

[15] Nanjing IASO Biotechnol Co Ltd, Nanjing, Peoples R China

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-290

引用

页码：S196 / S197

页数：2